ReviewHNO2026
[New developments in inner ear imaging for Meniere's disease].
Review in HNO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe current Bárány Society diagnostic criteria for Meniere's disease (MD) do not include radiological aspects. However, computed tomography (CT), native magnetic resonance imaging (MRI), and time-delayed contrast-enhanced inner ear MRI (iMRI) for visualization of endolymphatic hydrops (ELH) have been used in research for years.
objectiveThe aim of this narrative review is to present the current state of research and provide an outlook on future developments. Furthermore, existing possibilities for quantifying inner ear imaging data are shown. MATERIALS AND
methodsPubMed, MEDLINE, and EuropePMC were used for the literature search.
resultsSemiquantitative visual evaluation of ELH is increasingly supplemented by more accurate, objective quantification. Morphometric assessment of the vestibular aqueduct (VA) can be used for MM phenotyping, and analyses of contrast agent uptake in the endolymphatic duct located in the VA can help to differentiate between MM and vestibular migraine. Decreased vestibulocochlear nerve diameter can be associated with ELH. Image-based group analyses are currently under development.
conclusionMultimodal inner ear imaging can already contribute to the differential diagnosis of MM and other vestibular disorders. A lack of standardization and limited availability currently prevent its widespread use. In unclear cases, patients should be offered detailed inner ear imaging, both for differential diagnostic and scientific reasons.
Indexed as
Identifiers
41498927What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.